Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about NASDAQ:NKGN
Recent news which mentions NASDAQ:NKGN
NKGN Stock Earnings: NKGen Biotech Reported Results for Q1 2024
May 21, 2024
Tickers
NKGN
Tags
NKGN
Earnings Reports
NASDAQ:NKGN
From
InvestorPlace
NKGN Stock Earnings: NKGen Biotech Reported Results for Q4 2023
April 16, 2024
Tickers
NKGN
Tags
NASDAQ:NKGN
Market News
Earnings Reports
From
InvestorPlace
Why Is NKGen Biotech (NKGN) Stock Up 62% Today?
March 06, 2024
Tickers
NKGN
Tags
Today's Market
NKGN
Market News
From
InvestorPlace
Passage of the Amendment to the Advanced Regenerative Biotech Act a Positive Catalyst for Korean and Japanese Cell Therapy Companies
February 07, 2024
Tickers
NKGN
Tags
NASDAQ:NKGN
From
News Direct
NKGen Biotech Advances Alzheimer's Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial
December 29, 2023
Tickers
NKGN
Tags
NASDAQ:NKGN
From
News Direct
NKGEN Biotech Received FDA Approval for Clinical Trials of SKN01 NK Cell Therapy in Alzheimer’s Disease Treatment.
October 24, 2023
Tickers
NKGN
Tags
NASDAQ:NKGN
From
News Direct
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today